Lynne Sullivan
Director of Finance/CFO bei UNITY BIOTECHNOLOGY, INC.
Vermögen: 59 760 $ am 31.03.2024
Profil
Lynne Sullivan is currently serving as a Director at Bioverativ Therapeutics, Inc., Solid Biosciences, Inc., Inozyme Pharma, Inc., BiomX Ltd., Inheris Pharmaceuticals, Inc., and as the CFO & Head-Corporate Development at Unity Biotechnology, Inc. Previously, she held positions as an Independent Director at resTORbio, Inc., Director at KJT Group, Inc., Independent Director at BiomX, Inc., Senior Vice President-Finance at Biogen, Inc., Vice President-Tax at Merck KGaA, Chief Financial Officer at Compass Therapeutics LLC, Vice President-Tax at EMD Serono, Inc., and Tax Partner at Arthur Anderson & Co. Ms. Sullivan obtained a graduate degree from Bentley University in 1990 and an undergraduate degree from Suffolk University in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.05.2023 | 33 009 ( 0,20% ) | 54 135 $ | 31.03.2024 | |
BIOMX INC.
0,03% | 25.07.2023 | 12 500 ( 0,03% ) | 5 625 $ | 31.03.2024 |
INOZYME PHARMA, INC.
-.--% | 13.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
SOLID BIOSCIENCES INC.
-.--% | 06.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Lynne Sullivan
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLID BIOSCIENCES INC. | Director/Board Member | 01.11.2015 |
| INOZYME PHARMA, INC. | Director/Board Member | 01.05.2020 |
| UNITY BIOTECHNOLOGY, INC. | Director of Finance/CFO | 01.08.2020 |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Director/Board Member | - |
| Inheris Pharmaceuticals, Inc. | Director/Board Member | - |
Ehemalige bekannte Positionen von Lynne Sullivan
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMX INC. | Director/Board Member | 15.03.2024 |
| ADICET BIO, INC. | Director/Board Member | 15.09.2020 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01.08.2019 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Lynne Sullivan
| Bentley University | Graduate Degree |
| Suffolk University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| BIOGEN INC. | Health Technology |
| MERCK KGAA | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| SOLID BIOSCIENCES INC. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| BIOMX INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Arthur Anderson & Co. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
| Inheris Pharmaceuticals, Inc. | |
KJT Group, Inc.
 KJT Group, Inc. Miscellaneous Commercial ServicesCommercial Services KJT Group, Inc. is an evidence-based research and consulting firm. The private company is based in Rochester, NY. The company was founded in 2007 by Kenneth Tomaszewski. Michaela Gascon has been the CEO of the company since 2007. | Commercial Services |
